TROPIC
Company Snapshot
Company Overview
Tropic Biosciences U.K. Ltd. uses CRISPR gene-editing technologies to develop and market high-performing varieties of tropical crops, such as coffee and bananas. The main focus is to address disease in bananas and caffeine content in coffee.
For bananas, Tropic Biosciences addresses resistance to a key fungus causing significant damage in the Asia-Pacific region and Australia that is spreading to Africa and the Middle East.
For coffee, Tropic Biosciences is silencing genes that develop caffeine, thus creating a decaffeinated coffee that doesn’t require extensive chemical and heat processing to remove the caffeine. Additional traits being addressed include increased solubility to make processing instant coffee more efficient.
In September 2021, the company launched a new website for GEiGS, its technology platform.
TROPIC In News
Company's Business Segments
- Product : Gene-Edited Crop Varieties, GEiGS Technology Platform, Others
- Service : Genome Editing Services, Research and Development, Partnerships, Others
Applications/End User Industries
- Agriculture
- Biotechnology
- Supply Chain
- Consumer Markets
- CRISPR
- Gene editing